About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 624 record(s)
Req # A-2019-000863
The curriculum vitae for Tim Singer, Director General, Environmental and Radiation Health Sciences Directorate Health Canada / Government of Canada tim.singer@canada.ca / Also provide the educational background and the whole employment history.Organization: Health Canada
February 2021
Req # A-2019-000664
Adverse Reaction Reports (AERs). Report numbers: 00687833, E2B_02262269, 000674703,000623426, 000726342, 000600636, E2B_00897545.Organization: Health Canada
February 2021
Req # A-2019-001278
Adverse Drug Reaction (ADR). Report number: E2B_02541863.Organization: Health Canada
February 2021
Req # A-2019-001356
Adverse Reaction Reports (AERs) for TECTA. Report numbers: 000723891, 000724086, 000726262, 000726671, 000726861, 000726884, 000727408, E2B_02499932, E2B_02502451, E2B_02537531, E2B_02563972, E2B_02568693,E2B_02569171, E2B_02582439, E2B_02590468, E2B_02606636, E2B_02638026,E2B_02661867, E2B_02663573, E2B_02683261, E2B_02685618.Organization: Health Canada
February 2021
Req # A-2020-000433
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection sites. Report number: E2B_03021475.Organization: Health Canada
February 2021
Req # A-2020-000434
Adverse Drug Reaction (ADR) for botulinum toxin A. Report number: E2B_03031191.Organization: Health Canada
February 2021
Req # A-2019-001700
Adverse Reaction Report (AER) for CANCIDAS. Report number: 000673581. AERs for COZAAR: E2B_00343874, E2B_00006383, E2B_00780183. AERs for CUBICIN: 000671530, 000675609, 000678055, 000681798, E2B_00811328. AERs for ELOCOM: 000665808, 000668329. AER for ESTROGEL: E2B_00069057. AER for EZETROL: 000660782. AERs for FOSAMAX: E2B_00861041, E2B_00872783, E2B_00314459, 000662681, 000664222, E2B_00256053, E2B_00427075, E2B_00452948, 000674809, E2B_00037382, 000670515, 000680488.Organization: Health Canada
February 2021
Req # A-2019-001730
Adverse Reaction Reports (AERs) for FEIBA. Report numbers: 000728925, 000728954, 000728956, 000729683.Organization: Health Canada
February 2021
Req # A-2020-000095
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02760068, E2B_02709373, E2B_02670994, E2B_02680663, 732557, E2B_02817540, E2B_02818125, E2B_02819943,E2B_02823147, E2B_02826161, E2B_02826720, E2B_02827568, E2B_02828565,E2B_02829962, E2B_02830241, E2B_02831835, E2B_02831954, E2B_02832966,E2B_02845265, E2B_02846502.Organization: Health Canada
February 2021
Req # A-2020-000215
Adverse Reaction Reports (AERs) for FOSAMAX. Report numbers: 000665829, 000667215, E2B_00483641, E2B_00498826, E2B_00500827,E2B_00498902, E2B_00644065, E2B_00506460, E2B_00785350, E2B_00786948,E2B_00786970, E2B_00791529, E2B_00792724, E2B_00803504, 000670145, 000675266, E2B_00066044, E2B_00452948.Organization: Health Canada
February 2021